The All-Party Parliamentary Group on Beauty, Aesthetics and Wellbeing (APPGBAW) recently published its final report into botulinum toxin, dermal fillers and other aesthetic non-surgical cosmetic treatments.1
The year-long inquiry was commissioned to investigate how standards for undertaking and advertising cosmetic treatments and the relating regulatory and legislative structures, should be improved to support the aesthetics industry and protect public safety. This report follows the 2013 Review of the Regulation of Cosmetic Interventions led by Professor Sir Bruce Keogh, which concluded that ‘dermal fillers are a crisis waiting to happen’.2
The APPG made a total of 17 recommendations, which were based on evidence given in public inquiry sessions and submissions from stakeholders including associations, training providers, practitioners, aesthetic industry operators, health regulatory…
